Growth Metrics

Boston Scientific (BSX) Assets Average (2016 - 2026)

Boston Scientific's Assets Average history spans 18 years, with the latest figure at $44.0 billion for Q1 2026.

  • On a quarterly basis, Assets Average rose 10.67% to $44.0 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $44.0 billion, a 10.67% increase, with the full-year FY2025 number at $41.5 billion, up 11.45% from a year prior.
  • Assets Average hit $44.0 billion in Q1 2026 for Boston Scientific, up from $43.2 billion in the prior quarter.
  • Over the last five years, Assets Average for BSX hit a ceiling of $44.0 billion in Q1 2026 and a floor of $32.1 billion in Q3 2022.
  • Historically, Assets Average has averaged $36.6 billion across 5 years, with a median of $35.9 billion in 2024.
  • Biggest five-year swings in Assets Average: rose 0.48% in 2022 and later increased 12.08% in 2025.
  • Tracing BSX's Assets Average over 5 years: stood at $32.2 billion in 2022, then grew by 7.39% to $34.6 billion in 2023, then increased by 11.99% to $38.7 billion in 2024, then grew by 11.5% to $43.2 billion in 2025, then increased by 1.9% to $44.0 billion in 2026.
  • Business Quant data shows Assets Average for BSX at $44.0 billion in Q1 2026, $43.2 billion in Q4 2025, and $42.1 billion in Q3 2025.